Use access key #2 to skip to page content.
$0.62 0.00 (0.00%)
7/23/2008 3:36 PM

Hana Biosciences, Inc. (HNAB)

CAPS Rating:
No stars

A development stage biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to advance cancer care.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

HNAB doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

20 Outperforms
3 Underperforms
 

All-Stars

5 Outperforms
0 Underperforms
 

Wall Street

2 Outperforms
0 Underperforms
 

Members bullish on HNAB are also bullish on:

Members bearish on HNAB are also bearish on:

Ticker Tags

Micro Cap (4824), Biotechnology (294)
Suggest a tag

Hana Biosciences, Inc. At A Glance

Current Price: $0.62
Last Trade Time: 7/23/2008 3:36 PM
Open: $0.00
Previous Close: $0.62
Daily Range: $0.61 - $0.62
52-Week Range: $0.59 - $1.89
Volume: 12,221
Market Cap: $19.95M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

HNAB VS S&P 500 (SPY)

HNAB 12 month chart vs. S&P

News & Discussion Boards

Sorry no news articles available for HNAB.

Top Bull Pitch

Recs

1

Hana Biosciences, Inc. (HNAB)

Avatar fullwealth (99.69) Submitted: 3/05/07 12:21 PM

ride the index back up

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Hana Biosciences, Inc. (HNAB)

Avatar Joe1962 (64.37) Submitted: 3/12/07 1:05 PM

Into development, and with many competitiors, a risky stock. With the change of directors, Im sure it will take a bit of time to get things rolling. The phase clinicals take time. If something gets into phase three, and eventually passes, then the stock will go up. A good low stock to buy into, and ...More

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 5  

Recs

1

 (HNAB)

Avatar Joe1962 (64.37) Submitted: 3/12/07 1:05 PM : Underperform Start Price: $4.04 HNAB Score: 75.59

Into development, and with many competitiors, a risky stock. With the change of directors, Im sure it will take a bit of time to get things rolling. The phase clinicals take time. If something gets into phase three, and eventually passes, then the stock will go up. A good low stock to buy into, and hold at the moment, but it could be bought out too, small volumn.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (HNAB)

Avatar fullwealth (99.69) Submitted: 3/05/07 12:21 PM : Outperform Start Price: $3.93 HNAB Score: -76.61

ride the index back up

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (HNAB)

Avatar greenie001 (41.96) Submitted: 2/22/07 10:38 AM : Outperform Start Price: $5.03 HNAB Score: -75.35

Oversold

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (HNAB)

Avatar bioman100 (< 20) Submitted: 8/24/06 10:05 PM : Outperform Start Price: $7.38 HNAB Score: -90.35

prostate drug in development, oral navelbine, good pipeline.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (HNAB)

Avatar RBBioContest06 (< 20) Submitted: 5/31/06 10:46 PM : Outperform Start Price: $9.11 HNAB Score: -93.63

Picked by CLICK101

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 5  

Wall Street

Results 1 - 2 of 2  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackCollinsStew 43.53 02/21/07 Outperform NS $4.93-87.42%-12.28%-75.14
TrackJimCramer 81.36 04/28/06 Outperform 3W $11.81-94.75%-2.24%-92.51

Results 1 - 2 of 2  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners